These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy. Khuri FR Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):53-62. PubMed ID: 12108898 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis. Des Guetz G; Uzzan B; Nicolas P; Valeyre D; Sebbane G; Morere JF Crit Rev Oncol Hematol; 2012 Dec; 84(3):340-9. PubMed ID: 22534083 [TBL] [Abstract][Full Text] [Related]
7. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies]. Langer F; Helsberg K; Schütte WH; Leschinger MI Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of the unresectable non small cell lung carcinoma]. Spásová I Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938 [TBL] [Abstract][Full Text] [Related]
9. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326). Belani CP; Fossella F Cancer; 2005 Dec; 104(12):2766-74. PubMed ID: 16288485 [TBL] [Abstract][Full Text] [Related]
10. The current status of docetaxel for advanced non-small cell lung cancer. Green MR Anticancer Drugs; 2001 Feb; 12 Suppl 1():S11-6. PubMed ID: 11340898 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of advanced NSCLC in special patient population. Gridelli C; Maione P; Rossi A; Guerriero C; Ferrara C; Del Gaizo F; Colantuoni G; Nicolella D; Napolitano L Ann Oncol; 2006 May; 17 Suppl 5():v72-8. PubMed ID: 16807469 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in stage-IV NSCLC. Reck M; Gatzemeier U Lung Cancer; 2004 Aug; 45 Suppl 2():S217-22. PubMed ID: 15552802 [TBL] [Abstract][Full Text] [Related]
13. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial. Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA; Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340 [TBL] [Abstract][Full Text] [Related]
14. Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbine. Stupp R; Bodmer A; Duvoisin B; Bauer J; Perey L; Bakr M; Ketterer N; Leyvraz S Oncology; 2001; 61 Suppl 1():35-41. PubMed ID: 11598413 [TBL] [Abstract][Full Text] [Related]
15. [Stage IV NSCLC. Place of chemotherapy]. Meert AP Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S107-12. PubMed ID: 18971834 [TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy in cancer of the lung]. Gütz S MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578 [TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872 [TBL] [Abstract][Full Text] [Related]